Composition
- Active ingredients
- PATISIRAN SODIUM EQ 10MG BASE/5ML (EQ 2MG BASE/ML)
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA210922.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Onpattro
- Active substance
- patisiran sodium
- Route
- Intravenous
- Dosage form
- Solution
- Applicant
- Alnylam Pharms Inc
- Status
- Prescription
- FDA approval
- 10 Aug 2018
- Application
- NDA210922-001